ClinicalTrials.Veeva

Menu

Solid Organ Transplant Recipients With SARS-CoV-2 French Registry (TX-COVID)

U

University Hospital, Strasbourg, France

Status

Unknown

Conditions

SARS-CoV-2

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Patients with comorbid condition are known to be at high risk of severe forms of Covid-19. It is highly probable that immunocompromised patients like solid organ transplant (SOT) recipients are also at risk of severe forms of Covid-19. For this purpose, The investigators conducted a nationwide multicentric and multiorgan Registry to collect data about all French SOT recipients who develop a SARS-CoV-2 infection. The aim is to describe the clinical, biological and virological characteristics of these patients and to give information about evolution and prognosis of these particular population

Enrollment

300 estimated patients

Sex

All

Ages

1+ year old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All Solid Organ Transplant recipients with a functioning graft and a high suspicion or a confirmed SARS-CoV-2 infection
  • Adult and pediatric

Exclusion criteria

  • There are no exclusion criteria, except for the patient's explicit refusal to participate

Trial contacts and locations

1

Loading...

Central trial contact

Saïd CHAYER, PhD, HDR; Sophie CAILLARD, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems